ClearPoint Neuro的收入在2025年Q3增加了22%,但由于研发支出增加,净损失扩大。 ClearPoint Neuro's revenue rose 22% in Q3 2025, but net loss widened due to higher R&D spending.

据ClearPoint Neuro报告,2025年第三季度财政结果显示,收入为1 420万美元,比去年同期增加22%,原因是其神经外科导航系统的销售量增加。 ClearPoint Neuro reported third quarter 2025 financial results showing revenue of $14.2 million, a 22% increase from the same period last year, driven by higher sales of its neurosurgical navigation systems. 该公司还报告由于研发费用增加,净损失为810万美元,而上一年损失为690万美元。 The company also reported a net loss of $8.1 million, compared to a loss of $6.9 million in the prior year, due to increased research and development expenses. ClearPoint指出,随着临床环境越来越多地采用其平台,它继续扩大其在美国和国际的商业足迹。 ClearPoint stated it continues to expand its commercial footprint in the U.S. and internationally, with growing adoption of its platform in clinical settings.